Theranostics Market Statistical Forecast, Trade Analysis from 2024 | Top key players - Theragnostics Ltd., NuView Life Sciences, GE Healthcare.

The latest report published by DataM Intelligence highlights the growth prospects of Theranostics market. The industry expansion is majorly driven by developments in technology across the globe.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/theranostics-market?sz

The Global Theranostics Market reached USD 1.8 billion in 2022 and is expected to witness lucrative growth by reaching up to USD 4.2 billion by 2031. The global theranostics market is expected to exhibit a CAGR of 11.3% during the forecast period (2024-2031).

The Theranostics Market combines therapeutic and diagnostic approaches to offer personalized treatments, enabling targeted therapies based on specific disease characteristics. By integrating diagnostics with therapeutics, it helps in monitoring treatment effectiveness in real-time. This approach is revolutionizing healthcare, particularly in oncology, where it allows for more precise and efficient management of cancer, improving patient outcomes.

Competitive Evaluation:

Companies covered in this report are GE Healthcare, Jubilant Pharmova Limited (Jubilant Pharma Limited), Theragnostics Ltd., NuView Life Sciences, Lantheus Holdings, Inc., CapVest Limited (Curium Pharma), Clarity Pharmaceuticals, Cardinal Health, LLC, Advanced Accelerator Applications, and ITM Isotopen Technologien München AG among others.

The Theranostics Market analysis identifies a number of major market players. It enables companies to understand the strategies and partnerships used by other industry players to combat market competition. The comprehensive market report provides a fascinating microscopic look at the market. Corporations can detect the footprints of manufacturers by learning about demand, the global price of manufacturers, and the global benefit of manufacturing companies.

Key Development

On February 22, 2022, Theragnostics announced that its radiodiagnostic imaging drug, NephroScan, received Marketing Approval from the US Food and Drug Administration (FDA). NephroScan is designed to assist in evaluating renal parenchymal disorders in both adult and pediatric patients, including term neonates.

On February 10, 2022, Theragnostics, a company specializing in the development of radiopharmaceuticals for cancer imaging and treatment, revealed that its novel I-123 PARPi (THG-009) therapeutic agent was awarded an Innovation Passport by the UK Medicines and Healthcare Products Regulatory Agency (MHRA). This designation was granted for the treatment of primary and recurrent Glioblastoma Multiforme (GBM) as part of the MHRA's Innovative Licensing and Access Pathway (ILAP), aimed at accelerating the development and access to innovative medicines in the UK.

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/theranostics-market

Theranostics Market Segments

The report covers the segmentation of the market into different segments based on various classifications such as applications, end users, product types, and others. The segmentation is divided into two sections, one for development and the other for different roles, needs, and behaviors.

By Application: Oncology, Neurological Disorder, Cardiovascular Disease and Others.

By Radioisotopes: Technetium-99, Gallium-68, Lutetium (Lu) 177, Iodine-131, Zirconium-89 , Y-90 and Others.

By End User: Hospitals, Cancer Research Institutes, Diagnostic Centers and Others.

Regional Assessment:

Regional analysis includes segmentation based on the geography that accentuates the recent and future demand for Theranostics market across North America, Europe, Asia-Pacific, Middle East & Africa, and South America. The study also focuses on the demand for each application segment over all the prominent regions.

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

In terms of geographical analysis, Theranostics Market report provides an in-depth view of:-

∎ Regional level break-up
∎ Leading growth rates
∎ Countries with the largest market share
∎ Market factors
∎ Latest developments
∎ Industry challenges
∎ Regulatory policies
∎ Player strategies

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/theranostics-market

This report provides a 360-degree synopsis of the competitive scenario of the Theranostics industry. It has enormous awareness joined to the ongoing item and technical improvements in the business sector. It has a thorough analysis of the impact of the potential future development of these headways, a wide-ranging review of those extensions available for future growth.

Benefits of the Report:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.

➡ Top-down and bottom-up approach for regional analysis

➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.

➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market

Browse More Reports: https://www.datamintelligence.com/research-report/theranostics-market

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.